We demonstrated that, in distinction to classical opioid receptors, ACKR3 does not set off classical G protein signaling and is not modulated through the classical prescription or analgesic opioids, like morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists for instance naloxone. Alternatively, we proven that LIH383, an ACKR3-selective https://paulo404lgz4.livebloggs.com/profile